These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23952551)
41. Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion. Iversen PL; Mata J; Tracewell WG; Zon G Antisense Res Dev; 1994; 4(1):43-52. PubMed ID: 8061515 [TBL] [Abstract][Full Text] [Related]
42. Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation. Hvam ML; Cai Y; Dagnæs-Hansen F; Nielsen JS; Wengel J; Kjems J; Howard KA Mol Ther; 2017 Jul; 25(7):1710-1717. PubMed ID: 28641935 [TBL] [Abstract][Full Text] [Related]
43. Toxicological properties of several novel oligonucleotide analogs in mice. Henry SP; Zuckerman JE; Rojko J; Hall WC; Harman RJ; Kitchen D; Crooke ST Anticancer Drug Des; 1997 Jan; 12(1):1-14. PubMed ID: 9051110 [TBL] [Abstract][Full Text] [Related]
44. Phosphorothioate oligonucleotides: effectiveness and toxicity. Iannitti T; Morales-Medina JC; Palmieri B Curr Drug Targets; 2014; 15(7):663-73. PubMed ID: 24655142 [TBL] [Abstract][Full Text] [Related]
45. Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis. Ramazeilles C; Mishra RK; Moreau S; Pascolo E; Toulmé JJ Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7859-63. PubMed ID: 8058724 [TBL] [Abstract][Full Text] [Related]
46. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides. Iwamoto N; Butler DCD; Svrzikapa N; Mohapatra S; Zlatev I; Sah DWY; Meena ; Standley SM; Lu G; Apponi LH; Frank-Kamenetsky M; Zhang JJ; Vargeese C; Verdine GL Nat Biotechnol; 2017 Sep; 35(9):845-851. PubMed ID: 28829437 [TBL] [Abstract][Full Text] [Related]
47. Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers. Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U Biochem J; 2008 Jun; 412(2):307-13. PubMed ID: 18271753 [TBL] [Abstract][Full Text] [Related]
48. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Zhao Q; Temsamani J; Iadarola PL; Jiang Z; Agrawal S Biochem Pharmacol; 1996 Jan; 51(2):173-82. PubMed ID: 8615886 [TBL] [Abstract][Full Text] [Related]
49. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. Monia BP; Johnston JF; Sasmor H; Cummins LL J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854 [TBL] [Abstract][Full Text] [Related]
55. In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats. Ponnappa BC; Dey I; Tu GC; Zhou F; Aini M; Cao QN; Israel Y J Pharmacol Exp Ther; 2001 Jun; 297(3):1129-36. PubMed ID: 11356938 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides. Grossen P; Portmann M; Koller E; Duschmalé M; Minz T; Sewing S; Pandya NJ; van Geijtenbeek SK; Ducret A; Kusznir EA; Huber S; Berrera M; Lauer ME; Ringler P; Nordbo B; Jensen ML; Sladojevich F; Jagasia R; Alex R; Gamboni R; Keller M Eur J Pharm Biopharm; 2021 Jan; 158():198-210. PubMed ID: 33248268 [TBL] [Abstract][Full Text] [Related]
57. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides. Østergaard ME; De Hoyos CL; Wan WB; Shen W; Low A; Berdeja A; Vasquez G; Murray S; Migawa MT; Liang XH; Swayze EE; Crooke ST; Seth PP Nucleic Acids Res; 2020 Feb; 48(4):1691-1700. PubMed ID: 31980820 [TBL] [Abstract][Full Text] [Related]
59. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. Smith JB; Wickstrom E J Natl Cancer Inst; 1998 Aug; 90(15):1146-54. PubMed ID: 9701364 [TBL] [Abstract][Full Text] [Related]
60. Oligonucleotide treatment of ras-induced tumors in nude mice. Wickstrom E Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]